Ross Harricks

Ventracor Ltd. manufactures and markets a range of cardiac technology products. The company has developed an implantable blood pump, the VentrAssist left ventricular assist device, designed as therapy for patients in end stage heart failure. It also engages in the research, development, manufacture, clinical trials and commercialization of the VentrAssist LVAD and related technologies. Ventracor was founded in 1986 and is headquartered in Sydney, Australia.

Ventracor Ltd. manufactures and markets a range of cardiac technology products. The company has developed an implantable blood pump, the VentrAssist left ventricular assist device, designed as therapy for patients in end stage heart failure. It also engages in the research, development, manufacture, clinical trials and commercialization of the VentrAssist LVAD and related technologies. Ventracor was founded in 1986 and is headquartered in Sydney, Australia.

Ventracor Ltd. manufactures and markets a range of cardiac technology products. The company has developed an implantable blood pump, the VentrAssist left ventricular assist device, designed as therapy for patients in end stage heart failure. It also engages in the research, development, manufacture, clinical trials and commercialization of the VentrAssist LVAD and related technologies. Ventracor was founded in 1986 and is headquartered in Sydney, Australia.

Part of ResMed, Inc., ResMed Pty Ltd. is an Australian company that offers a range of insomnia treatments and snoring solutions. ResMed is based in Bella Vista, AU. Insomnia, defined as an inability to fall asleep or stay asleep, affects many people and can lead to symptoms of sleep deprivation. ResMed provides products to help individuals regain healthy sleep. The private company also offers solutions for snoring, including behavioral and lifestyle changes, anti-snoring devices, surgery, and CPAP therapy.